The role of ramucirumab and pembrolizumab combination in patients with advanced non-small cell lung cancer, gastroesophageal adenocarcinoma, or urothelial carcinoma
Year: 2020
Type: article
Source: Chinese Clinical Oncology
DOI: 10.21037/cco-20-132
Authors: Jane E. Rogers, Jaffer A. Ajani
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W3036263921